Chr. Hansen Holding — M&A Activity 2016

Feb 18, 2016

CHR HANSEN Improving food & health

COMPANY ANNOUNCEMENT

NO. 4 / 2016

18 February 2016

Chr. Hansen closes acquisition of Nutrition Physiology Company

The Chr. Hansen Group has received regulatory clearance and completed the previously announced acquisition of Nutrition Physiology Company (NPC) from NPC Guardian Holding LLC (ref. announcement no. 1/2016) for cash consideration reflecting an enterprise value of USD 185 million.

CEO of Chr. Hansen Holding A/S, Cees de Jong

"Today, we welcome 50 new Chr. Hansen employees and I'm very excited to start the journey we have ahead to help farmers improve productivity and health through natural means. The combined business of Chr. Hansen and NPC creates a broader platform in animal health, which is pivotal in our pursuit of future growth within microbial solutions to the livestock industry".

NPC is a provider of microbial solutions to the US livestock industry, especially within the beef cattle segment. The company was founded in 1993 and is headquartered in Overland Park, Kansas, USA. Key products are Bovamine®, Bovamine® Defend™, Bovamine® Dairy and PoultriMax®.

Further information on the transaction will be communicated in connection with the Q2 report on 7 April.

For further information, please contact:

Anders Mohr Christensen, Senior Director, Investor Relations

Tel: +45 4574 7618

Klara Halkjaer, Head of Media Relations

Tel: +45 5339 2362

Forward-looking statements

This announcement contains forward-looking statements. Such statements are subject to risks and uncertainties, as various factors, many of which are beyond the control of Chr. Hansen Holding A/S, may cause actual developments and results to differ materially from the expectations expressed in this announcement.

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2014/15 financial year was EUR 859 million. It has more than 2,600 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen. For further information, please visit www.chr-hansen.com.

Chr. Hansen Holding A/S - Closes acquisition of Nutrition Physiology Company

Chr. Hansen Holding A/S

Boege Allé 10-12

DK-2970, Hoersholm

Denmark

Tel. +45 45 74 74 74

www.chr-hansen.com

CVR-no: 28318677